Dr. Lili Zhang 张莉莉
Chief Physician
Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and chemotherapy for malignant tumors, with a focus on medical treatment for breast cancer, lung cancer, and gastrointestinal cancers.
Dr. Zhang has nearly 26 years of experience in medical oncology, specializing in the diagnosis and comprehensive treatment of breast, lung, and gastrointestinal cancers. Dr. Zhang manages chemotherapy complications and has led a Jiangsu Provincial Natural Science Foundation project. Dr. Zhang participated in multiple international and domestic multicenter clinical trials for new drugs and protocols and published papers in provincial core journals.
Professional roles
- Member, Jiangsu Branch of the Chinese Medical Association
- Deputy Leader, Breast Cancer Group of the Oncology Chemotherapy and Biological Therapy Branch, Jiangsu Medical Association
- Member, Breast Cancer Professional Committee, China Anti-Cancer Association
- Member, Breast Cancer Professional Committee, Jiangsu Cancer Prevention and Control Alliance
Name order: in Chinese the family name comes first (Zhang Lili). Papers usually list the name as Lili Zhang or Zhang L.
Selected publications
22 papers on PubMed matched by name and affiliation; 2 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2021 (first author): Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study. PubMed 34336688
- Ann Palliat Med, 2021 (senior author): The successful application of pyrotinib in the treatment of primary trastuzumab-resistant HER-2-positive breast cancer with bilateral axillary lymph node metastasis: a case report. PubMed 34237992
- PLoS One, 2015 (senior author): MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2. PubMed 26107945
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion